Kinea Bio Overview

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 1

Kinea Bio General Information

Description

Operator of a biotechnology company intended to accelerate the development of next-generation AAV-based gene therapies to treat neuromuscular diseases. The company offers novel targeting and gene regulation technologies such as advanced engineered tissue modeling capabilities, and splicing strategies, enabling patients to address the most critical challenges facing the field and the landscape of gene therapy.

Contact Information

Website
www.kineabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3000 Western Avenue
  • Seattle, WA 98121
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • 3000 Western Avenue
  • Seattle, WA 98121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kinea Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 19-Feb-2024 $500K Completed Startup
To view Kinea Bio’s complete valuation and funding history, request access »

Kinea Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kinea Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Parent Project Muscular Dystrophy Not-For-Profit Venture Capital Minority
To view Kinea Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Kinea Bio FAQs

  • Where is Kinea Bio headquartered?

    Kinea Bio is headquartered in Seattle, WA.

  • What is the size of Kinea Bio?

    Kinea Bio has 6 total employees.

  • What industry is Kinea Bio in?

    Kinea Bio’s primary industry is Biotechnology.

  • Is Kinea Bio a private or public company?

    Kinea Bio is a Private company.

  • What is Kinea Bio’s current revenue?

    The current revenue for Kinea Bio is .

  • How much funding has Kinea Bio raised over time?

    Kinea Bio has raised $500K.

  • Who are Kinea Bio’s investors?

    Parent Project Muscular Dystrophy has invested in Kinea Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »